Dyne Therapeutics Inc

+0.61 (+4.30%)
4:01:18 PM EDT: $14.79 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Dyne Therapeutics Inc Stock, NASDAQ:DYN

1560 Trapelo Road, Waltham, Massachusetts 02451
United States of America
Phone: +1.781.786.8230
Number of Employees: 95


Dyne Therapeutics, Inc. engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystroph. The company was founded by Jason P. Rhodes and Romesh R. Subramanian on December 1, 2017 and is headquartered in Waltham, MA.